RxDoctor Payments Data

Katie Brennan

Primary Care · Helena, MTNPI 1265873319

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $147,873 of the $183,168 with a category attached, or 80.7%. AbbVie accounts for 60.1% of it on its own, with 3 other manufacturers making up the rest. Among primary care clinicians in MT with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$183,168in general payments, 2019–2025

Across 334 payments — averaging $548.41 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$110K
  • Galderma Laboratories, L.p.$52K
  • Revance Therapeutics, Inc.$18K
  • Merz North America, Inc.$3K

What the payments were for

  • Consulting fees$5000%
  • Speaking & faculty fees$147,87381%
  • Travel & lodging$26,96515%
  • Food & beverage$7,8294%

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie(2 entities)215$110,090
Galderma Laboratories, L.p.75$51,950
Revance Therapeutics, Inc.25$18,155
Merz North America, Inc.19$2,973

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$183,168 in reported general payments places this provider in the 95th percentile of 20 primary care providers in Montana.

See all primary care providers in Montana →

Other primary care in Helena

See the full list for Montana →

Where these figures come from

Is this you, or does something look wrong? →